LivePerson And 2 Other Stocks Under $2 Insiders Are Buying
LivePerson And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 75 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Cartesian Therapeutics
- The Trade: Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Director Timothy A Springer acquired a total of 1,185,872 shares an average price of $0.56. To acquire these shares, it cost around $666,222.
- What's Happening: On March 18, HC Wainwright & Co. analyst Mitchell Kapoor reiterated Cartesian Therapeutics with a Buy and maintained a $2 price target.
- What Cartesian Therapeutics Does: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company.
Aware
- The Trade: Aware, Inc. (NASDAQ:AWRE) CEO and President Robert A Eckel acquired a total of 13,735 shares at at an average price of $1.67. To acquire these shares, it cost around $22,881.
- What's Happening: On March 12, Aware reported a year-over-year decrease in fourth-quarter EPS results..
- What Aware Does: Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people.
LivePerson
- The Trade: LivePerson, Inc. (NASDAQ:LPSN) Director Vanessa Pegueros acquired a total of 5,000 shares at an average price of $1.02. The insider spent around $5,100 to buy those shares.
- What's Happening: On Feb. 28, LivePerson reported mixed fourth-quarter financial results and issued 2024 total revenue guidance below estimates.
- What LivePerson Does: LivePerson Inc is the enterprise leader in digital customer conversation.
Don't forget to check out our premarket coverage here
The Dow Jones index closed higher by around 75 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週一收高約75點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
Cartesian Therapeutics
笛卡爾療法
- The Trade: Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Director Timothy A Springer acquired a total of 1,185,872 shares an average price of $0.56. To acquire these shares, it cost around $666,222.
- What's Happening: On March 18, HC Wainwright & Co. analyst Mitchell Kapoor reiterated Cartesian Therapeutics with a Buy and maintained a $2 price target.
- What Cartesian Therapeutics Does: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company.
- 交易：Cartesian Therapeutics, Inc.（納斯達克股票代碼：RNAC）董事蒂莫西·斯普林格 共收購了1,185,872股股票 平均價格爲0.56美元。收購這些股票的成本約爲666,222美元。
- 發生了什麼：3月18日，HC Wainwright & Co. 分析師米切爾·卡普爾重申了Cartesian Therapeutics的買入，並維持了2美元的目標股價。
- Cartesian Therapeutics做什麼：Cartesian Therapeutics Inc是一家臨床階段的生物製藥公司。
Aware
意識到
- The Trade: Aware, Inc. (NASDAQ:AWRE) CEO and President Robert A Eckel acquired a total of 13,735 shares at at an average price of $1.67. To acquire these shares, it cost around $22,881.
- What's Happening: On March 12, Aware reported a year-over-year decrease in fourth-quarter EPS results..
- What Aware Does: Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people.
- The Trade：Aware, Inc.（納斯達克股票代碼：AWRE）首席執行官兼總裁羅伯特·埃克爾 共收購了13,735股股票 平均價格爲1.67美元。收購這些股票的成本約爲22,881美元。
- 發生了什麼：3月12日，Aware報告稱，第四季度每股收益同比下降。
- Aware做什麼：Aware Inc是生物識別行業的軟件和服務提供商。該公司的軟件產品用於政府和商業生物識別系統，以識別或驗證人員。
LivePerson
直播人物
- The Trade: LivePerson, Inc. (NASDAQ:LPSN) Director Vanessa Pegueros acquired a total of 5,000 shares at an average price of $1.02. The insider spent around $5,100 to buy those shares.
- What's Happening: On Feb. 28, LivePerson reported mixed fourth-quarter financial results and issued 2024 total revenue guidance below estimates.
- What LivePerson Does: LivePerson Inc is the enterprise leader in digital customer conversation.
- 交易：LivePerson, Inc.（納斯達克股票代碼：LPSN）董事凡妮莎·佩格羅斯 共收購了 5,000 股股票 平均價格爲1.02美元。知情人士花費了約5,100美元購買了這些股票。
- 發生了什麼：2月28日，LivePerson公佈的第四季度財務業績喜憂參半，併發布了低於預期的2024年總收入指導。
- LivePerson做什麼：LivePerson Inc是數字客戶對話領域的企業領導者。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧